Apoptosis mediated by phosphatidylcholine-specific phospholipase C is associated with cAMP. p53 level, and cell-cycle distribution in vascular endothelial cells

Endothelium: Journal of Endothelial Cell Research

Volumn 10, Issue 3, 2003, Pages 141-147

  Du, Chunqing ^a   Zhao, Qitao ^a   Araki, Satohiko ^b   Zhang, Shangli ^a   Miao, Junying ^a  

^a SHANDONG UNIVERSITY   (China)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Apoptosis; cAMP; Cell cycle; p53; PC PLC; Vascular endothelial cells

Indexed keywords

CYCLIC AMP; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C; PROTEIN P53; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL SURVIVAL; CELLULAR DISTRIBUTION; DATA ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0142120471     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320390233445     Document Type: Article

References (34)

1. Babcock G.F. (1999) Quantitation of phagocytosis by confocal microscopy. Methods in Enzymology, 307, 319-328.
2. Cifone M.G., Roncaioli P., De Maria R., Camarda G., Santoni A., Ruberti G., and Testi R. (1995) Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO Journal, 14, 5859-5868.
3. Clarke A.R., Gledhill S., Hooper M.L., Bird C.C., and Wyllie A.H. (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene, 9, 1767-1773.
4. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., and Wyllie A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
5. Halstead J., Kemp K., and Ignotz R.A. (1995) Evidence for involvement of phosphatidyl-choline-phospholipase C and protein kinase C in transforming growth factor-beta signaling. Journal of Biological Chemistry, 270, 13600-13603.
6. Hippenstiel S., Schmeck B., N'Guessan P.D., Seybold J., Krull M., Preissner K., Eichel-Streiber C.V., and Suttorp N. (2002) Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am J Physiol Lung Cell Mol Physiol, 283, L830-L838.
7. Haugland R.P. (1996) Handbook of Fluorescent Probes and Research Chemicals. Eugene, OR: Molecular Probes.
8. Jaffe E.A., Nachman R.L., Becker C.G., and Minick R.C. (1973) Culture of human endothelial cells derived from umbilical veins. Journal of Clinical Investigation, 52, 2745-2756.
9. Lau W.K., Yeung C.W., Lui P.W., Cheung L.H., Poon N.T., and Yung K.K.L. (2002) Different trends in modulation of NMDAR1 and NMDAR2B gene expression in cultured cortical and hippocampal neurons after lead exposure. Brain Research, 932, 10-24.
10. Li Y.-H., Maher P., and Schubert D. (1998) Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proceedings of the National Academy of Science of the United States of America, 95, 748-753.
11. Lobb R.R., and Fett J.W. (1984) Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. Biochemistry, 23, 6295-6296.
12. Lotem J., and Sachs L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
13. Machleidt T., Kramer B., Adam D., Neumann B., Schutze S., Wiegmann K., and Kronke M. (1996) Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. Journal of Experimental Medicine, 184, 725-733.
14. Martin S.J., and Calif S.D. (1997) Apoptosis and Cancer. Basel, Switzerland: Karger Landes Systems.
15. Maxwell S.A., and Davis G.E. (2000) Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proceedings of the National Academy of Science of the United States of America, 97, 3009-3014.
16. Meikrantz W., and Schlegel R. (1996) Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. Journal of Biological Chemistry, 271, 10205-10209.
17. Miao J.Y., Araki S., Han Y.R., and Hiroshi H. (1999) Involvement of gene expression in apoptosis of vascular endothelial cells induced by rattlesnake venom. Cell Research, 9, 237-243.
18. Miao J.Y., Araki S., Zhang S.L., and Hayasi H. (2000) 1-Methyl-ε-isobutylxanthine delays apoptosis induced by deprivation of growth factors in vascular endothelial cells. Acta Pharmacologica Sinica, 21, 936-938.
19. Miao J.Y., Kaji K., Hayashi H., and Araki S. (1997) Suppression of apoptosis by inhibition of phosphatidylcholine-specific phospholipase C in vascular endothelial cells. Endothelium, 5, 231-239.
20. Monick M.M., Carter A.B., Gudmundsson G., Mallampalli R., Powers L.S., and Hunninghake G.W. (1999) A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. Journal of Immunology, 162, 3005-3012.
21. Muller-Decker K. (1989) Interruption of TPA-induced signals by antiviral and antitumoral xanthate compond: Inhibition of a phospholipase C-type reaction. Biochemical Biophysical Research Communications, 162, 198-201.
22. Muller Igaz L., Refojo D., Costas M.A., Holsboer F., and Arzt E. (2002) CRE-mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death. Biochimica Biophysica Acta, 1542, 139-148.
23. Murphy M., Mabruk M.J., Lenane P., Liew A., McCann P., Buckley A., Flatharta C.O., Hevey D., Billet P., Robertson W., Javed S., Leader M., Kay E., and Murphy G.M. (2002) Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation. Journal of Clinical Pathology, 55, 829-833.
24. Naro F., Sette C., Vicini E., Arcangelis V.D., Grange M., Conti M., Lagarde M., Molinaro M., Adamo S., and Némoz G. (1999) Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Molecular Biology of the Cell, 10, 4355-4367.
25. Papadimitriou E., Waters C.R., Manolopoulos V.G., Unsworth B.R., Maragoudakis M.E., and Lelkes P.I. (2001) Regulation of extracellular matrix remodeling and MMP-2 activation in cultured rat adrenal medullary endothelial cells. Endothelium, 8, 181-194; 8, 243-253.
26. Parvathenani L.K., Buescher E.S., Chacon-Cruz E., and Beebe S.J. (1998) Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. Journal of Biological Chemistry, 273, 6736-6743.
27. 2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. Journal of Agriculture and Food Chemistry, 50, 677-684.
28. Rastogi K.S., Cooper R.L., Shi Z.Q., and Vranic M. (1997) Quantitative measurement of islet glucagon response to hypoglycemia by confocal fluorescence imaging in diabetic rats: Effects of phlorizin treatment. Endocrine, 7, 367-375.
29. Ritchie A., and Broxmeyer H.E. (1999) Suppression of p53-mediated growth factor withdrawal-induced apoptosis in the myeloid compartment by hematopoietic cytokines: An overview of hematopoiesis and apoptosis with a presentation of thrombopoietin and the M07E cell line as a model system. Critical Review in Oncology and Hematology, 31, 169-191.
30. Schutze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., and Kronke M. (1992) TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell, 71, 765-776.
31. Simarro M., Calvo J., Vila J.M., Places L., Padilla O., Alberola-Ila J., Vives J., and Lozano F. (1999) Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. Journal of Immunology, 162, 5149-5155.
32. Van Dijk M.C., Hilkmann H., and Van Blitterswijk W.J. (1997) Platelet-derived growth factor activation of mitogen-activated protein kinase depends on the sequential activation of phosphatidylcholine-specific phospholipase C, protein kinase C-zeta and Raf-1. Biochemical Journal, 325, 303-307.
33. Yamamoto H., Hanada K., and Nishijima M. (1997) Involvement of diacylglycerol production in activation of nuclear factor kappaB by a CD14-mediated lipopolysaccharide stimulus. Biochemical Journal, 325, 223-228.
34. Zhou D.H., Lauderback C.M., Yu T., Brown S.A., Butterfield A., and Thompson J.S. (2001) D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. Journal of Pharmacology and Experimental Therapeutics, 298, 103-109.